• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    8/25/22 12:36:29 PM ET
    $AGFY
    $ANF
    $APGN
    $AUD
    Farming/Seeds/Milling
    Consumer Staples
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $AGFY alert in real time by email

     

    On Thursday, 63 companies set new 52-week lows.

    Areas of Interest About Today's 52-Week Lows:

    • Sanofi (NASDAQ:SNY) was the largest firm on a market cap basis to set a new 52-week low.
    • Gaucho Group Holdings (NASDAQ:VINO) is the smallest company on a market cap basis to set a new 52-week low.
    • Bit Brother (NASDAQ:BTB) shares dropped the most, trading down 16.9% to reach its new 52-week low.
    • Gannett Co (NYSE:GCI) was the most promising stock of the group, with shares actually trading up 0.0% to bounce back after reaching its new 52-week low.

    The following stocks achieved new 52-week lows on Thursday:

    • Sanofi (NASDAQ:SNY) shares fell to $39.92 on Thursday, setting a new 52-week low with a shift of down 1.28%.
    • Elanco Animal Health (NYSE:ELAN) stock broke to a new 52-week low of $15.98 on Thursday. Shares of the company traded up 0.9%.
    • Nordstrom (NYSE:JWN) shares were up 1.75% for the day, having made a 52-week low of $18.28.
    • IHS Holding (NYSE:IHS) stock set a new 52-week low of $6.81 on Thursday, moving up 0.29%.
    • CureVac (NASDAQ:CVAC) stock hit a yearly low of $10.95. The stock was down 0.91% for the day.
    • Hudson Pacific Properties (NYSE:HPP) shares moved up 1.26% on Thursday to hit a new 52-week low of $13.66, drifting up 1.26%.
    • Washington REIT (NYSE:WRE) shares were up 0.5% for the day, having made a 52-week low of $19.99.
    • Piedmont Office Realty (NYSE:PDM) stock hit a new 52-week low of $12.14. The stock was down 1.05% on the session.
    • Compass (NYSE:COMP) shares fell to $3.17 on Thursday, setting a new 52-week low with a shift of down 1.37%.
    • Sturm Ruger & Co (NYSE:RGR) stock hit a yearly low of $54.14. The stock was down 0.47% for the day.
    • Abercrombie & Fitch (NYSE:ANF) shares made a new 52-week low of $15.90 on Thursday. The stock was down 2.63% for the day.
    • Office Props IT (NASDAQ:OPI) stock achieved a new 52-week low on Thursday morning, hitting $18.51 and moving up 0.86%.
    • Phibro Animal Health (NASDAQ:PAHC) stock hit a new 52-week low of $16.47. The stock was down 3.28% on the session.
    • Forge Global Holdings (NYSE:FRGE) stock drifted up 1.68% on Thursday morning to hit a new 52-week low of $3.21.
    • Industrial Logistics (NASDAQ:ILPT) stock broke to a new 52-week low of $8.11 on Thursday. Shares of the company traded down 0.1%.
    • Starbox Group Hldgs (NASDAQ:STBX) stock hit a yearly low of $8.24. The stock was down 9.77% for the day.
    • Akili (NASDAQ:AKLI) shares moved down 8.16% on Thursday to hit a new 52-week low of $4.63, drifting down 8.16%.
    • PetIQ (NASDAQ:PETQ) shares hit a yearly low of $11.33. The stock was down 2.13% on the session.
    • Pharvaris (NASDAQ:PHVS) shares hit a yearly low of $9.88. The stock was up 0.2% on the session.
    • Gannett Co (NYSE:GCI) shares were 0.0% (flat) for the day, having made a 52-week low of $2.16.
    • Software Acquisition Gr (NASDAQ:SWAG) shares made a new 52-week low of $8.76 on Thursday. The stock was down 9.5% for the day.
    • Fossil Group (NASDAQ:FOSL) stock dropped to a yearly low on Thursday of $4.46. Shares traded up 0.22%.
    • Superior Gr of Cos (NASDAQ:SGC) stock achieved a new 52-week low on Thursday morning, hitting $13.23 and moving down 1.34%.
    • Oportun Financial (NASDAQ:OPRT) shares were down 0.33% for the day, having made a 52-week low of $6.04.
    • Natures Sunshine Products (NASDAQ:NATR) stock achieved a new 52-week low on Thursday morning, hitting $9.65 and moving down 2.07%.
    • First Savings Financial (NASDAQ:FSFG) shares fell to $23.14 on Thursday, setting a new 52-week low with a shift of up 0.04%.
    • Delta Apparel (AMEX:DLA) shares set a new 52-week low of $19.14. The stock traded up 0.38%.
    • Apexigen (NASDAQ:APGN) stock hit a new 52-week low of $4.63. The stock was down 6.51% on the session.
    • Finance of America (NYSE:FOA) shares fell to $1.37 on Thursday, setting a new 52-week low with a shift of up 1.48%.
    • Audacy (NYSE:AUD) shares moved down 0.31% on Thursday to hit a new 52-week low of $0.54, drifting down 0.31%.
    • Rekor Systems (NASDAQ:REKR) stock dropped to a yearly low on Thursday of $1.41. Shares traded 0.0% (flat).
    • Nuvve Holding (NASDAQ:NVVE) stock achieved a new 52-week low on Thursday morning, hitting $3.03 and moving down 4.39%.
    • Quince Therapeutics (NASDAQ:QNCX) shares fell to $1.82 on Thursday, setting a new 52-week low with a shift of 0.0% (flat).
    • Dogness (Intl) (NASDAQ:DOGZ) stock dropped to a yearly low on Thursday of $1.46. Shares traded down 1.32%.
    • Genius Gr (AMEX:GNS) stock broke to a new 52-week low of $2.63 on Thursday. Shares of the company traded down 7.64%.
    • Eyenovia (NASDAQ:EYEN) shares moved up 3.69% on Thursday to hit a new 52-week low of $1.52, drifting up 3.69%.
    • Network-1 Technologies (AMEX:NTIP) shares made a new 52-week low of $2.16 on Thursday. The stock was up 0.45% for the day.
    • Forza X1 (NASDAQ:FRZA) stock set a new 52-week low of $4.38 on Thursday, moving down 1.31%.
    • Reborn Coffee (NASDAQ:REBN) shares set a new 52-week low of $2.72. The stock traded down 12.8%.
    • Erytech Pharma (NASDAQ:ERYP) shares hit a yearly low of $0.95. The stock was down 15.66% on the session.
    • Digital Ally (NASDAQ:DGLY) shares set a new yearly low of $0.65 this morning. The stock was down 5.85% on the session.
    • mCloud Technologies (NASDAQ:MCLD) stock hit $1.98 on Thursday morning, setting a new 52-week low for a change of down 3.41%.
    • Innovative Eyewear (NASDAQ:LUCY) shares made a new 52-week low of $3.31 on Thursday. The stock was down 0.86% for the day.
    • Agrify (NASDAQ:AGFY) stock hit a yearly low of $0.80. The stock was down 9.14% for the day.
    • Paramount Gold Nevada (AMEX:PZG) stock drifted up 8.63% on Thursday morning to hit a new 52-week low of $0.33.
    • Ever-Glory Intl Gr (NASDAQ:EVK) shares fell to $1.06 on Thursday, setting a new 52-week low with a shift of up 3.58%.
    • Nephros (NASDAQ:NEPH) stock broke to a new 52-week low of $1.38 on Thursday. Shares of the company traded up 0.72%.
    • FG Finl Gr (NASDAQ:FGF) shares moved down 1.42% on Thursday to hit a new 52-week low of $1.35, drifting down 1.42%.
    • Reliance Global Group (NASDAQ:RELI) stock hit a yearly low of $0.68. The stock was down 4.11% for the day.
    • Taoping (NASDAQ:TAOP) stock hit $0.68 on Thursday morning, setting a new 52-week low for a change of down 6.0%.
    • Unique Fabricating (AMEX:UFAB) stock set a new 52-week low of $0.92 on Thursday, moving 0.0% (flat).
    • Trxade Health (NASDAQ:MEDS) shares made a new 52-week low of $1.03 on Thursday. The stock was down 7.83% for the day.
    • Gaucho Group Holdings (NASDAQ:VINO) shares were up 8.07% for the day, having made a 52-week low of $0.26.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $ANF
    $APGN
    $AUD

    CompanyDatePrice TargetRatingAnalyst
    Quince Therapeutics Inc.
    $QNCX
    1/30/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Sanofi
    $SNY
    1/27/2026Neutral
    Citigroup
    Compass Inc.
    $COMP
    1/27/2026$14.00Neutral
    Goldman
    Compass Inc.
    $COMP
    1/26/2026$15.00Overweight
    Analyst
    Elanco Animal Health Incorporated
    $ELAN
    1/22/2026Neutral → Overweight
    Piper Sandler
    Abercrombie & Fitch Company
    $ANF
    1/21/2026$135.00Neutral → Buy
    Citigroup
    Compass Inc.
    $COMP
    1/20/2026Hold → Buy
    Deutsche Bank
    Sanofi
    $SNY
    1/16/2026Buy → Neutral
    UBS
    More analyst ratings

    $AGFY
    $ANF
    $APGN
    $AUD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quince Therapeutics downgraded by Citizens JMP

    Citizens JMP downgraded Quince Therapeutics from Mkt Outperform to Mkt Perform

    1/30/26 6:43:10 AM ET
    $QNCX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Citigroup initiated coverage on Sanofi

    Citigroup initiated coverage of Sanofi with a rating of Neutral

    1/27/26 8:49:24 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman resumed coverage on Compass with a new price target

    Goldman resumed coverage of Compass with a rating of Neutral and set a new price target of $14.00

    1/27/26 8:45:14 AM ET
    $COMP
    EDP Services
    Technology

    $AGFY
    $ANF
    $APGN
    $AUD
    SEC Filings

    View All

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    2/6/26 10:09:38 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Genius Group Limited

    6-K - Genius Group Ltd (0001847806) (Filer)

    2/6/26 9:00:18 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 144 filed by Abercrombie & Fitch Company

    144 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Subject)

    2/5/26 4:24:49 PM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AGFY
    $ANF
    $APGN
    $AUD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kurzius Lawrence Erik bought $213,000 worth of shares (10,000 units at $21.30), increasing direct ownership by 8% to 131,773 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/16/25 4:42:47 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N bought $478,496 worth of shares (22,000 units at $21.75) (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/15/25 4:41:24 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Modi Rajeev A. bought $95,985 worth of shares (4,500 units at $21.33), increasing direct ownership by 4% to 123,082 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/15/25 4:43:23 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ANF
    $APGN
    $AUD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026

    NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE:ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, March 4, 2026, at 8:30 a.m. ET. A press release detailing the company's fourth quarter and full year results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the fourth quarter and full year results will be available on the company's website at approximately 7:30 a.m. ET. Conference Call:To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.  Webcast:To listen to a live w

    2/6/26 8:00:00 AM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    COLDWELL BANKER COMMERCIAL AFFILIATES ANNOUNCES 2025 YEAR-END AWARD WINNERS

    MADISON, N.J., Feb. 5, 2026 /PRNewswire/ -- Coldwell Banker Commercial Affiliates today announced its 2025 year-end award winners, recognizing the highest-performing companies and professionals across its global network with the introduction of the 1906 Club, the brand's most prestigious distinction. Formerly known as the Top 2% and Elite Company awards, the 1906 Club honors top revenue-producing companies and the top 2% of affiliated professionals nationwide, based on 2025 transaction revenue. Award recipients will be formally recognized at the 2026 Coldwell Banker Commercial

    2/5/26 1:54:00 PM ET
    $COMP
    EDP Services
    Technology

    IHS Towers Confirms Approach by MTN Group Limited

    IHS Holding Limited, (NYSE:IHS) ("IHS Towers" or the "Company"), one of the largest independent owners, operators and developers of shared communications infrastructure in the world by tower count, today issues the following statement to its shareholders and the market in general having noted the Cautionary Announcement distributed on February 5, 2026, by MTN Group Limited ("MTN") regarding a potential acquisition of further shares of the Company. IHS Towers confirms that discussions are ongoing with MTN regarding a potential acquisition by MTN of all remaining shares it does not already own in IHS Towers. The approach is non-binding, has not been agreed and there is no certainty that a

    2/5/26 10:25:00 AM ET
    $IHS
    Telecommunications Equipment
    Telecommunications

    $AGFY
    $ANF
    $APGN
    $AUD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ANF
    $APGN
    $AUD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Horowitz Fran sold $6,920,168 worth of shares (67,031 units at $103.24), decreasing direct ownership by 17% to 338,272 units (SEC Form 4)

    4 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Issuer)

    2/6/26 4:55:25 PM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Chairman and CEO Reffkin Robert L. converted options into 1,154,593 shares and covered exercise/tax liability with 638,797 shares (SEC Form 4)

    4 - Compass, Inc. (0001563190) (Issuer)

    2/6/26 4:30:30 PM ET
    $COMP
    EDP Services
    Technology

    President and CEO Bendheim Jack converted options into 30,000 shares and sold $545,473 worth of shares (13,180 units at $41.39) (SEC Form 4)

    4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)

    2/5/26 7:22:29 PM ET
    $PAHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ANF
    $APGN
    $AUD
    Leadership Updates

    Live Leadership Updates

    View All

    Coldwell Banker Real Estate Announces 2025 Year-End Award Winners

    The brand recognizes the top affiliated sales professionals, teams, offices and companies who have demonstrated exceptional performance across multiple sales categories in the past year MADISON, N.J., Jan. 29, 2026 /PRNewswire/ -- Coldwell Banker Real Estate LLC today announced the 2025 recipients of its annual year-end awards, recognizing top‑ranking performers whose achievements exemplify the highest standards of excellence across the Coldwell Banker® network. "Each year, the dedication of the Coldwell Banker real estate professionals, teams, and offices elevates the standar

    1/29/26 10:00:00 AM ET
    $COMP
    EDP Services
    Technology

    Coro Appoints Eyal Hen as Chief Financial Officer

    Veteran public-company finance leader joins Coro to support global scale and the company's next phase of growth Coro, the leading cybersecurity platform for Lean IT-driven organizations, today announced the appointment of Eyal Hen as its new Chief Financial Officer, effective immediately. Hen will oversee Coro's global finance organization as the company accelerates international growth and continues building the financial foundation to support its next stage of scale. "As Coro grows globally, we're deliberately investing in leadership that brings exactly what we need right now: public-company financial discipline combined with operational experience scaling global teams," said Joe Syko

    1/21/26 9:00:00 AM ET
    $REKR
    Telecommunications Equipment
    Telecommunications

    Finance of America Appoints Angela Tribelli as Chief Marketing Officer

    Award-winning consumer and growth marketing leader joins FOA to strengthen category leadership and accelerate awareness of modern retirement solutions Finance of America ("FOA" or the "Company"), one of the nation's leading providers of home-equity-based financing solutions for a modern retirement, today announced the appointment of Angela Tribelli as Chief Marketing Officer, effective January 2, 2025. Tribelli will report to FOA President Kristen Sieffert and will be based in New York. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106942290/en/Angela Tribelli, Chief Marketing Officer of Finance of America In this role, Tr

    1/6/26 8:30:00 AM ET
    $FOA
    Finance: Consumer Services
    Finance

    $AGFY
    $ANF
    $APGN
    $AUD
    Financials

    Live finance-specific insights

    View All

    Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026

    NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE:ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, March 4, 2026, at 8:30 a.m. ET. A press release detailing the company's fourth quarter and full year results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the fourth quarter and full year results will be available on the company's website at approximately 7:30 a.m. ET. Conference Call:To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.  Webcast:To listen to a live w

    2/6/26 8:00:00 AM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Superior Group of Companies Declares Regular Quarterly Cash Dividend

    ST. PETERSBURG, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Superior Group of Companies, Inc. (NASDAQ:SGC) today announced that it has declared a quarterly dividend of $0.14 per share, payable February 27, 2026, to shareholders of record as of February 16, 2026. About Superior Group of Companies, Inc. (SGC):Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC's commitment

    2/5/26 8:40:00 AM ET
    $SGC
    Apparel
    Consumer Discretionary

    Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

    Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Diluted earnings per share of $0.67, an increase of $0.59 Adjusted EBITDA of $68.1 million, an increase of $19.9 million, or 41% Adjusted net income of $35.7 million, an increase of $13.5 million, or 60% Adjusted dil

    2/4/26 4:25:00 PM ET
    $PAHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ANF
    $APGN
    $AUD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Office Properties Income Trust

    SC 13G - OFFICE PROPERTIES INCOME TRUST (0001456772) (Subject)

    12/17/24 8:04:10 PM ET
    $OPI
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care